These guides are AI-generated educational summaries — not legal or medical advice.
C&P Exam Prep: Skin Diseases (Dermatitis / Psoriasis / Acne)
DBQ Overview
Interview + Physical- Form Name
- Skin_Diseases
- Form Code
- Skin_Diseases
- Page Count
- 12
- Examiner Type
- Dermatologist or appropriate clinician
- Estimated Duration
- 15-30 minutes
- Exam Format
- Interview + Physical
What to Expect During Your Exam
Exam Overview
To document the current severity, extent, and treatment of your skin condition for VA disability rating purposes under 38 CFR - 4.118 using the General Rating Formula for the Skin. The examiner will determine what percentage of your total body surface area (TBSA) and exposed body surface area (EBSA) is affected, whether your condition is active or in remission, and what treatments you require.
What the examiner evaluates:
- Specific diagnosis and ICD code for your skin condition(s)
- Total body surface area (TBSA) affected, expressed as a percentage
- Exposed body surface area (EBSA) affected, expressed as a percentage
- Whether the condition is currently active or in remission
- Current and past treatments including medications, phototherapy, biologics, and procedures
- Severity descriptors: superficial vs. deep lesions, nodules, cysts, plaques
- Location of involvement: face/neck, intertriginous areas, palmar/plantar surfaces, mucosal involvement
- Presence of complications such as psoriatic arthritis, nail involvement, or oral mucosal involvement
- Impact on daily activities, work, and quality of life
- History of the condition including onset, course, flare-ups, and remissions
- Whether the veteran has previously had skin conditions that have since resolved
The examiner will conduct a physical inspection of your skin. Be prepared to undress partially so all affected areas can be visually examined. The exam typically includes a structured interview about your symptoms, treatment history, and functional impact. Photographs may be taken to document lesion distribution and severity. Under M21-1 guidance, the DBQ must identify both TBSA and EBSA percentages for the rating to be sufficient.
Typical duration: 15-30 minutes
Total Body Surface Area (TBSA) Assessment
The percentage of your entire body surface covered by the skin condition. This is a core rating factor under the General Rating Formula for the Skin.
What to expect:
The examiner will visually inspect your entire body and estimate the percentage of skin affected by your condition. The Rule of Nines or similar dermatological estimation methods may be used. You should expose all affected areas, including scalp, trunk, extremities, and intertriginous zones.
Key thresholds:
- Less than 5% TBSA — May support 0% or 10% rating depending on treatment requirements
- 5%-19% TBSA or requiring systemic therapy — May support 30% rating
- 20%-39% TBSA — May support 30% rating
- 40%-59% TBSA — May support 50% rating
- 60% or more TBSA or incapacitating episodes requiring systemic therapy -6 weeks/year — May support 60% rating
Tips:
- Point out ALL affected areas before the exam ends, including areas currently in remission that still scar or discolor
- Mention scalp involvement separately as it is often overlooked
- Describe your worst flare-up if your skin looks better on exam day than usual
- Ask the examiner to document both TBSA and EBSA - the DBQ requires both for a sufficient rating
Pain considerations: Describe any pain, burning, or stinging associated with skin lesions, especially during flares. Note if touching or pressure on plaques or lesions causes pain, as this can support additional functional limitations.
Exposed Body Surface Area (EBSA) Assessment
The percentage of normally exposed body surface area (face, neck, hands, forearms, lower legs, feet) affected by your condition. EBSA is critical because involvement of visible areas may affect employment and social functioning.
What to expect:
The examiner will specifically note lesions on your face, neck, hands, forearms, and other areas typically visible in daily life. Some rating decisions give additional weight to visible or exposed-area involvement.
Key thresholds:
- Less than 40% of face and neck affected — Lower severity tier for facial/neck involvement
- 40% or more of face and neck affected — Higher severity tier; may support higher rating and employability considerations
- Intertriginous areas affected (axilla, anogenital, under breasts) — Elevated severity; these areas are especially debilitating and painful
Tips:
- Do not wear concealing makeup or clothing to hide lesions on exam day
- If lesions on face/neck are worse during flares, describe that verbally even if less visible at exam time
- Mention hand and foot involvement explicitly - palmar and plantar involvement is tracked separately on the DBQ
- Note whether facial involvement has caused social withdrawal, employment issues, or psychological distress
Pain considerations: Facial and hand lesions can cause significant functional impairment. Describe difficulty with tasks requiring fine motor skills when hands are affected, or how facial involvement impacts daily interactions.
Acne Severity Classification
For acne, the examiner classifies whether lesions are superficial (comedones, papules, pustules) or deep (inflamed nodules, pus-filled cysts) and determines body area distribution. Under DC 7828, severity drives the rating.
What to expect:
The examiner will look for comedones, papules, pustules, inflamed nodules, and cysts. They will note the location (face/neck vs. body) and percentage of affected area. For chloracne (DC 7822), the exam is particularly detailed given its association with toxic exposures.
Key thresholds:
- Superficial acne (comedones, papules, pustules only) — Typically 0% unless affecting 40%+ of face/neck
- Deep acne (nodules and cysts) affecting body areas other than face/neck — Supports 10% rating
- Deep acne affecting less than 40% of face and neck — Supports 30% rating
- Deep acne affecting 40% or more of face and neck, OR affecting intertriginous areas — Supports 60% rating
Tips:
- If your acne fluctuates, describe your typical worst presentation, not just what is visible today
- Note any scarring from past cysts or nodules as evidence of prior severity
- Clearly distinguish between superficial and deep lesions when describing your condition
- For chloracne, document any toxic or chemical exposure in service explicitly
Pain considerations: Deep acne nodules and cysts can be extremely painful. Describe pain level, tenderness to touch, and any impact on wearing clothing, using equipment, or physical contact in your military occupational specialty.
Rating Criteria Breakdown
| Rating % | Criteria | Key Symptoms |
|---|---|---|
| 60% | At least one of the following: systemic therapy required for a total of at least 12 weeks during the past 12-month period, or 20%-39% of the total body surface area is affected during the past 12-month period. |
CFR: Under the General Rating Formula for the Skin, 60% reflects severe skin involvement or high treatment burden requiring systemic therapy for at least 12 weeks per year. |
| 30% | At least one of the following: systemic therapy required for a total of at least six weeks during the past 12-month period, or 5%-19% of the total body surface area is affected during the past 12-month period. |
CFR: Under the General Rating Formula for the Skin, 30% reflects moderate skin involvement or a treatment burden requiring systemic therapy for at least 6 weeks per year. |
| 10% | At least one of the following: topical therapy required over past 12-month period, or area of skin involved is less than 5% of total body surface area (TBSA). Condition requires ongoing management but is not severely disabling. |
CFR: Under the General Rating Formula for the Skin, 10% reflects a condition requiring at least topical therapy or involving a small body surface area. |
| 0% | No disability, or the skin condition is controlled with no more than topical therapy. Condition is in remission or causes minimal symptoms that do not require ongoing treatment. |
CFR: Under the General Rating Formula for the Skin (38 CFR - 4.118), a 0% rating reflects a condition present but causing no disability warranting compensation. |
60% At least one of the following: systemic therapy required for ...
At least one of the following: systemic therapy required for a total of at least 12 weeks during the past 12-month period, or 20%-39% of the total body surface area is affected during the past 12-month period.
Key Symptoms
- 20% to 39% TBSA affected
- Requires systemic therapy (oral agents or biologics) for -12 weeks per year
- Severe itching, pain, scaling, and inflammation
- Significant impact on sleep, work, and social functioning
- Multiple medication regimens required
- Frequent dermatologist visits
CFR: Under the General Rating Formula for the Skin, 60% reflects severe skin involvement or high treatment burden requiring systemic therapy for at least 12 weeks per year.
30% At least one of the following: systemic therapy required for ...
At least one of the following: systemic therapy required for a total of at least six weeks during the past 12-month period, or 5%-19% of the total body surface area is affected during the past 12-month period.
Key Symptoms
- 5% to 19% TBSA affected
- Requires systemic therapy (oral corticosteroids, methotrexate, cyclosporine, etc.) for -6 weeks in the past year
- Significant itching, scaling, or inflammation
- Moderate impact on daily activities and sleep
- Condition requires monitoring by a dermatologist
CFR: Under the General Rating Formula for the Skin, 30% reflects moderate skin involvement or a treatment burden requiring systemic therapy for at least 6 weeks per year.
10% At least one of the following: topical therapy required over ...
At least one of the following: topical therapy required over past 12-month period, or area of skin involved is less than 5% of total body surface area (TBSA). Condition requires ongoing management but is not severely disabling.
Key Symptoms
- Requires prescription topical corticosteroids, calcineurin inhibitors, or other prescription topical agents
- Less than 5% TBSA affected
- Periodic flares requiring topical treatment
- Minimal impact on daily functioning
CFR: Under the General Rating Formula for the Skin, 10% reflects a condition requiring at least topical therapy or involving a small body surface area.
0% No disability, or the skin condition is controlled with no m ...
No disability, or the skin condition is controlled with no more than topical therapy. Condition is in remission or causes minimal symptoms that do not require ongoing treatment.
Key Symptoms
- Skin condition fully or largely in remission
- Controlled with over-the-counter or basic topical creams only
- No significant area of skin involvement
- No functional impairment
CFR: Under the General Rating Formula for the Skin (38 CFR - 4.118), a 0% rating reflects a condition present but causing no disability warranting compensation.
How to Describe Your Symptoms
Body Surface Area and Lesion Distribution
How to describe:
Describe the extent of your skin involvement using percentages where possible (e.g., 'My plaques cover roughly my entire back, both arms, and parts of my legs - I'd estimate about 30-40% of my body'). Name specific body regions: scalp, face, neck, trunk, extremities, palms, soles, and intertriginous areas (groin, armpits, under breasts). Distinguish between active lesions, healing areas, and post-inflammatory pigmentation or scarring.
Worst-day example:
“On my worst days, my psoriatic plaques cover nearly my entire back, both arms, and my scalp. The skin is cracked, bleeding in spots, and extremely tender. Even wearing a shirt is painful. I estimate about 35% of my body is covered at peak flares, which happen about monthly and last 2-3 weeks.”
What the examiner listens for:
Specific body regions affected, percentage estimates, chronicity of involvement, whether current exam day represents typical presentation or a better-than-usual day, presence of involvement in high-severity locations (face, hands, intertriginous areas).
Understatements to avoid:
Do not say 'it's not that bad right now' without also describing your worst presentation. Do not minimize scalp involvement or facial lesions. Do not forget to mention areas covered by clothing during the exam.
Treatment Burden and Systemic Therapy
How to describe:
List every medication you use for your skin condition - topical and systemic. Include the name, dose, how long you have been on it, and how many weeks per year you require it. For biologics or systemic agents, specify the exact therapy (e.g., methotrexate 15mg weekly, adalimumab every 2 weeks). Note any treatments you have tried and discontinued due to side effects or inadequate control.
Worst-day example:
“I have been on methotrexate for two years and also use high-potency topical steroids daily. I also completed a 12-week course of phototherapy last year. Despite all of this, I still have significant flares. The methotrexate requires monthly blood tests and causes fatigue and nausea.”
What the examiner listens for:
Whether systemic therapy has been required, total weeks per year on systemic agents, escalation of treatment over time, side effects of treatment (which reflect treatment burden), and whether the condition is controlled or refractory despite treatment.
Understatements to avoid:
Do not say you 'just use a cream' if you also take systemic medications. Do not underreport how many weeks per year you are on oral or injectable agents. Do not fail to mention biologics, immunosuppressives, or phototherapy.
Flares, Remissions, and Episodic Nature
How to describe:
Describe the frequency, duration, and severity of your flares. Note what triggers them (stress, cold weather, certain soaps, food, etc.). State how many weeks per year you experience active disease versus remission. Be explicit about whether today's exam reflects your typical condition or a period of relative improvement.
Worst-day example:
“I typically have 4-6 major flares per year, each lasting 3-4 weeks. During flares, I cannot sleep due to itching and pain, I miss work 1-2 days per week, and I avoid social situations due to embarrassment. I am currently in a partial remission, but this is not typical - most of the year I am dealing with active disease.”
What the examiner listens for:
Frequency and duration of flares, impact of flares on function and work, whether remissions are complete or partial, triggers, and whether the exam-day appearance is representative of the year-round condition.
Understatements to avoid:
Do not let a good exam day define your rating. If you have active disease most of the year, say so clearly. Do not forget to mention that your condition is episodic and today may not reflect your worst or typical presentation.
Functional and Occupational Impact
How to describe:
Explain how your skin condition affects your ability to work, perform daily tasks, sleep, and maintain social relationships. Mention specific limitations: inability to wear certain uniforms or clothing, difficulty using tools or equipment due to hand involvement, need to avoid sun exposure, inability to participate in physical training, and impact on mental health.
Worst-day example:
“During bad flares, I cannot grip tools because my palms are cracked and bleeding. I miss work because I cannot wear my uniform without severe skin irritation. I sleep only 2-3 hours a night due to intense itching. I have stopped socializing because of my appearance, which has contributed to depression.”
What the examiner listens for:
Specific functional limitations tied to the skin condition, impact on employment and employability, sleep disruption, psychological effects, and any secondary conditions caused or worsened by the skin disease.
Understatements to avoid:
Do not say you 'manage fine' without describing the accommodations required to do so. Do not omit psychological impact or social withdrawal. Do not downplay sleep disruption, which is a major functional consequence of severe skin conditions.
Complications and Associated Conditions
How to describe:
For psoriasis specifically, report any joint pain, stiffness, or swelling (psoriatic arthritis), nail changes (pitting, onycholysis, discoloration), or oral mucosal involvement. These complications are rated separately under additional diagnostic codes. Clearly describe each complication so the examiner can note it in the appropriate DBQ section.
Worst-day example:
“In addition to skin plaques, I have significant pain and swelling in my finger joints and both knees, which my doctor believes is psoriatic arthritis. My fingernails are pitted and partially separated from the nail bed. These joint problems make it difficult to walk more than one block and prevent me from doing most manual tasks.”
What the examiner listens for:
Joint symptoms suggesting psoriatic arthritis, nail dystrophy, mucosal involvement, presence of erythroderma or exfoliative dermatitis, vasculitis, scarring alopecia, and any systemic manifestations.
Understatements to avoid:
Do not assume joint pain is unrelated to your skin condition. Do not fail to mention nail changes, which are separately ratable. Do not overlook oral lesions or mucosal involvement if present.
Common Mistakes to Avoid
Presenting at exam during a period of remission without disclosing typical severity
Skin conditions are episodic. The examiner can only see what is present on exam day. If today is a good day, the DBQ will reflect minimal involvement and your rating may be significantly lower than warranted.
Instead: Explicitly tell the examiner: 'Today is not representative of my typical condition. My worst flares look like [description] and occur [frequency]. I am in a partial remission today.' Bring photos of your skin during active flares.
Impact: All levels - this mistake most commonly causes 0% or 10% ratings when 30% or higher is warranted
Failing to report all treatments including systemic agents and biologics
The number of weeks per year on systemic therapy is a key rating threshold under the General Rating Formula for the Skin. Failing to disclose all treatments (especially oral or injectable agents used for 6+ or 12+ weeks per year) can cause the rating to be scored at a lower tier.
Instead: Prepare a complete medication list including all topical and systemic treatments, the duration of each, and why they were prescribed. Include discontinued treatments that demonstrate the condition's severity over time.
Impact: 30% and 60% rating thresholds are directly tied to systemic therapy duration
Not mentioning complications such as psoriatic arthritis or nail involvement
Complications of psoriasis are rated separately and can significantly increase your overall combined rating. If you do not report them, the examiner will not document them in the DBQ, and VA will not know to rate them.
Instead: Proactively describe all complications: joint pain, stiffness, nail changes, oral lesions. Ask the examiner to note each one in the DBQ and request referral to appropriate specialists if needed.
Impact: Can prevent separate ratings for psoriatic arthritis (DC 5002) and nail conditions
Minimizing the percentage of body surface area affected
The TBSA percentage is one of the two primary quantitative criteria driving your rating tier. Veterans often downplay the extent of their condition or only reference areas visible on exam day.
Instead: Before the exam, use the Rule of Nines to estimate your typical affected area during active disease. Bring photos. Verbally describe your scalp, trunk, extremities, and hidden areas (groin, armpits, under breasts) in detail.
Impact: Directly determines whether you reach 10%, 30%, or 60% thresholds
Focusing only on appearance and not on functional limitations
The impact on your ability to work, sleep, and function in daily life is critical context that supports the rating and any secondary conditions (like PTSD, depression, or musculoskeletal conditions). Examiners are required to document functional impact.
Instead: Prepare specific examples of how your skin condition limits you: 'I cannot wear a collared shirt during flares,' 'I miss 1-2 days of work per month,' 'I have not slept more than 4 hours on nights with active flares.' Tie limitations to specific activities.
Impact: All levels - functional impact documentation supports rating accuracy and secondary condition claims
Not disclosing resolved or historical conditions
The DBQ has a section asking whether the veteran previously had skin conditions that have since resolved. A history of severe episodes, hospitalizations, or prior systemic treatment is relevant evidence of condition severity even if currently in remission.
Instead: Describe the full history of your condition: when it started, previous treatments including any hospitalizations, courses of systemic therapy, or procedures. Mention any periods of particularly severe disease even if they resolved.
Impact: Affects historical context and may support higher ratings or continuity of service-connection
Prep Checklist
Before Your Exam
Day Of
During the Exam
After the Exam
Your Rights During a C&P Exam
- You have the right to request that your C&P examination be recorded in most states, subject to applicable one-party or two-party consent laws. Notify the examiner at the beginning of the appointment.
- You have the right to review the completed DBQ and all exam records through your VA MyHealtheVet account or by submitting a formal records request.
- You have the right to submit a personal statement, buddy statements, and private medical opinions (nexus letters) to supplement the C&P exam evidence before VA issues its rating decision.
- You have the right to request a new or additional C&P examination if you believe the original exam was inadequate, incomplete, or failed to document your condition accurately.
- You have the right to bring a support person (spouse, family member, VSO representative) to your C&P exam, subject to facility rules. Confirm with the exam facility in advance.
- You have the right to be rated based on your worst-day or typical presentation, not solely on what the examiner observes on a single exam day. You should verbally describe your condition during flares if today is not representative.
- Under M21-1, a skin DBQ that does not identify both TBSA and EBSA percentages is considered insufficient for rating purposes. You can notify VA if these fields were not completed.
- You have the right to appeal any rating decision you believe is inaccurate by filing a Higher-Level Review (HLR), Supplemental Claim with new evidence, or Board of Veterans Appeals (BVA) appeal.
- Psoriasis complications such as psoriatic arthritis, nail involvement, and oral mucosal disease are separately ratable under additional diagnostic codes. You have the right to claim each complication separately.
- You are not required to accept the first rating assigned. If your condition worsens or new evidence becomes available, you may file for an increased rating at any time.
Related Conditions
- Psoriatic Arthritis Direct complication of psoriasis (DC 7816). Rated separately under DC 5002 (rheumatoid arthritis) or DC 5099 5002 by analogy. If you have joint pain, swelling, or stiffness associated with your psoriasis, file a separate claim for psoriatic arthritis.
- Scarring Alopecia May develop as a complication of scalp dermatitis, psoriasis, or discoid lupus. Rated separately under DC 7831. Document scalp involvement and any hair loss at your skin exam.
- Depression / Anxiety (Secondary to Skin Condition) Chronic skin conditions causing disfigurement, social withdrawal, and sleep disruption frequently cause or aggravate depression and anxiety. These may be claimed as secondary service connected conditions with a supporting medical nexus opinion.
- Sleep Disorders (Secondary to Skin Condition) Severe pruritus (itching) from dermatitis, eczema, or psoriasis can cause chronic sleep disruption and may support a secondary claim for insomnia or sleep disorder.
- Discoid Lupus Erythematosus A related autoimmune skin condition rated under DC 7809. If your skin condition has been diagnosed as discoid lupus or if lupus is suspected, it is evaluated under a separate diagnostic code and rating criteria.
- Eczema / Dermatitis Rated under DC 7806 under the same General Rating Formula for the Skin. Veterans with both dermatitis and psoriasis may have multiple skin conditions rated under separate diagnostic codes or combined.
- Chloracne (Chemical Acne) A specific form of acne caused by toxic chemical exposure (e.g., Agent Orange, dioxins). Rated under DC 7822 with unique rating criteria based on facial/neck involvement. If you have a history of herbicide or chemical exposure in service, this may be presumptively service connected.
Get Personalized C&P Exam Preparation
Upload your medical records for AI-powered prep that maps YOUR symptoms to the exact DBQ fields your examiner will evaluate.
This C&P exam preparation guide is for educational purposes only and does not constitute legal, medical, or claims advice. Always consult with a qualified Veterans Service Organization (VSO) representative or VA-accredited attorney for guidance specific to your claim. Never exaggerate, minimize, or fabricate symptoms during a C&P examination.